TLCD2 Activators
TLCD2 Activators encompass a variety of chemical compounds that indirectly stimulate the functional activity of TLCD2 through diverse signaling pathways. Forskolin, by raising intracellular cAMP levels, activates protein kinase A (PKA), which can then phosphorylate TLCD2, leading to its functional enhancement. Similarly, Sphingosine-1-phosphate functions through sphingosine-1-phosphate receptors to activate Rho family GTPases, influencing the activation state of TLCD2. The calcium ionophore Ionomycin increases intracellular calcium, activating calcium-dependent kinases that may phosphorylate TLCD2, thereby enhancing its activity. PMA, a PKC activator, also promotes the phosphorylation of TLCD2 via PKC pathways. U0126, a MEK inhibitor, and SB203580, a p38 MAPK inhibitor, both contribute to the modulation of various kinases and phosphatases that impact the phosphorylation and activity of TLCD2.
Furthermore, Epigallocatechin gallate (EGCG) inhibits several kinases that might otherwise phosphorylate inhibitory sites on proteins in TLCD2-associated pathways, thereby potentially increasing TLCD2 activity. Genistein, as a tyrosine kinase inhibitor, can bolster TLCD2's role by reducing competitive phosphorylation events. A23187 (Calcimycin) and Thapsigargin both disrupt calcium signaling, which may lead to the activation of TLCD2 throughcalcium-dependent kinases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate TLCD2, leading to its enhanced functional activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which can trigger pathways leading to the activation of Rho family GTPases, subsequently influencing the activation state of TLCD2. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin acts as a calcium ionophore that increases intracellular calcium concentrations, potentially activating calcium-dependent kinases that phosphorylate TLCD2, thus enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent PKC activator that can lead to the phosphorylation of targets downstream of PKC, including TLCD2, resulting in its functional enhancement. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a selective inhibitor of p38 MAPK, which can shift signaling dynamics to favor pathways that activate TLCD2, enhancing its functional activities. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several kinases, which can reduce inhibitory phosphorylations on proteins within pathways that include TLCD2, potentially enhancing its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore for Ca2+, increasing intracellular calcium and potentially enhancing the activation of calcium-dependent kinases that could phosphorylate and activate TLCD2. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein may enhance TLCD2 function by reducing competitive phosphorylation events, thereby indirectly promoting TLCD2's activity in its pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, which could lead to the activation of calcium-dependent kinases affecting TLCD2. | ||||||